Cargando…

663. Epidemiology and outcomes of recurrent C. difficile infection among hematopoietic cell transplant recipients

BACKGROUND: Recent updates in Clostridioides difficile infection (CDI) treatment guidelines among hematopoietic cell transplant (HCT) recipients recommend fidaxomicin as first line therapy as it reduces the risk of recurrent CDI. We aimed to characterize HCT recipients with CDI and describe their cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez, Eduardo, Krantz, Elizabeth M, Pergam, Steven A, Liu, Catherine, Tverdek, Frank P, Escobar, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677654/ http://dx.doi.org/10.1093/ofid/ofad500.726

Ejemplares similares

Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center
por: Lind, Margaret L., et al.
Publicado: (2021)

Unintended Consequences of Pre-transplant VRE Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients
por: Stohs, Erica, et al.
Publicado: (2017)

Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza
por: Sorey, Woody, et al.
Publicado: (2023)

1505. Antiviral and Antibiotic Prescribing Among Patients at an Ambulatory Cancer Center with Laboratory-Confirmed Influenza
por: Sorey, Woody, et al.
Publicado: (2020)

A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients
por: Sosa-Moreno, Andrea, et al.
Publicado: (2020)

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
por: Waghmare, Alpana, et al.
Publicado: (2020)

616. Vancomycin Is Frequently Administered to Hematopoietic Cell Transplant Recipients Without a Provider Documented Indication and Correlates with Microbiome Disruption and Adverse Events
por: Golob, Jonathan, et al.
Publicado: (2018)

1001. Feasibility and Outcomes of a Pre-Transplant Antibiotic Allergy Evaluation Program for Allogeneic Hematopoietic Cell Transplant (HCT) Candidates
por: Liu, Catherine, et al.
Publicado: (2019)

139. association of Physician Orders for Life-sustaining Treatment (POLST) with Antimicrobial Use at End of Life in Cancer Patients: An Antimicrobial Stewardship Opportunity
por: Kates, Olivia, et al.
Publicado: (2020)

Association of Physician Orders for Life-Sustaining Treatment With Inpatient Antimicrobial Use at End of Life in Patients With Cancer
por: Kates, Olivia S, et al.
Publicado: (2021)

Evaluating risk factors for Clostridiumdifficile infection in adult and pediatric hematopoietic cell transplant recipients
por: Boyle, Nicole M., et al.
Publicado: (2015)

Infections in Leukemia and Hematopoietic Stem Cell Transplantation
por: Pergam, Steven A., et al.
Publicado: (2011)

213. Prophylactic oral vancomycin for Clostridioides difficile in allogeneic hematopoietic stem cell transplant recipients
por: Ogawa, Lauren, et al.
Publicado: (2022)

2668. Β Lactam and Other Antibiotic Allergies in Patients Undergoing Solid-Organ and Hematopoietic Cell Transplantation
por: Imlay, Hannah, et al.
Publicado: (2019)

Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients
por: Johnson, Tanner M, et al.
Publicado: (2021)

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZV(IN)) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
por: Boeckh, Michael, et al.
Publicado: (2017)

Risk factors for healthcare-associated Clostridium difficile infection in pediatric hematopoietic stem cell transplant recipients
por: Drew, Richard H, et al.
Publicado: (2017)

Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy
por: Cheng, Guang-Shing, et al.
Publicado: (2016)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients
por: Yemişen, Mücahit, et al.
Publicado: (2016)

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients
por: Diorio, Caroline, et al.
Publicado: (2018)

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma E, et al.
Publicado: (2019)

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)
por: Dioverti, Veronica, et al.
Publicado: (2022)

Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy
por: Ford, Emily S., et al.
Publicado: (2023)

1082. Characterization of Ceftriaxone-Resistant Viridans Streptococci Bacteremia Among Patients at a Comprehensive Cancer Center
por: Marsland, Paula, et al.
Publicado: (2020)

Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017)

Epidemiology of Respiratory Viral Infections in Pediatric Solid Organ Transplant or Hematopoietic Stem Cell Transplant Recipients
por: Fisher, Brian T., et al.
Publicado: (2015)

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
por: Mullane, Kathleen M, et al.
Publicado: (2019)

1739. Epidemiology of Invasive Fungal Infections in Allogenic Hematopoietic Stem Cell Transplant Recipients in Utah
por: Zurko, Jessica, et al.
Publicado: (2019)

Tuberculosis in Hematopoietic Stem Cell Transplant Recipients
por: Ramos, Jéssica Fernandes, et al.
Publicado: (2013)

Infection in the Hematopoietic Stem Cell Transplant Recipient
por: Marty, Francisco M., et al.
Publicado: (2008)

Infections in Recipients of Hematopoietic Stem Cell Transplants
por: Young, Jo-Anne H., et al.
Publicado: (2015)

BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients
por: Odegard, Elizabeth A., et al.
Publicado: (2022)

Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection
por: Liang, Emily C., et al.
Publicado: (2022)

Cutaneous Legionella infections in allogeneic hematopoietic cell transplantation recipients
por: Vaidya, Toral, et al.
Publicado: (2020)

Clostridium difficile Infection in Solid Organ and Haematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma Elizabeth, et al.
Publicado: (2017)

Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
por: Benamu, Esther, et al.
Publicado: (2018)

Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections
por: Lind, Margaret L, et al.
Publicado: (2020)

Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients
por: Balletto, Elisa, et al.
Publicado: (2015)

Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients
por: Busca, Alessandro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u8cgvclaat95drqg2uelajchu6